Patients in Food Deserts Face Higher Complication Rates After Breast Reconstruction, Study Finds
Patients living in areas with limited access to healthy foods had higher rates of postoperative complications.
Patients living in areas with limited access to healthy foods had higher rates of postoperative complications.
Designed for use with the Symani system, the suture features a shorter length and modified needle curvature to support precision in microsurgical and supermicrosurgical cases.
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.
Engineered for implants up to 1500cc, the next-generation delivery system supports a “no-touch” technique to improve control, reduce friction, and minimize risks such as infection and capsular contracture.
Read MoreThe implant is designed to support tissue regrowth following lumpectomy and shows favorable safety and aesthetic outcomes in early results.
Read MoreFindings suggest that tools designed to elicit patient values can improve communication and support African American women in choosing between implant-based and autologous reconstruction after mastectomy.
Read MoreA look at the clinical need behind the MemoryGel Enhance launch—and how it’s expanding reconstructive options for patients with larger volume requirements.
Read MoreMore women are undergoing post-mastectomy reconstruction, but racial gaps remain.
Read MoreA surgical team at Rutgers and University Hospital is using robotics to improve breast reconstruction outcomes, with potential applications across other reconstructive procedures.
Read MoreFor women undergoing autologous breast reconstruction—reconstruction using the patient’s own tissues, rather than implants—the risks of overall and specific complications are increased at higher body mass index (BMI) levels.
Read MoreTI Surgical has received U.S. FDA approval for a clinical study to assess Cortiva Allograft Dermis in breast reconstruction, a step toward obtaining FDA pre-market approval for the implants.
Read MoreIn this episode, Dr Elisabeth Potter, who specializes in DIEP flap breast procedures, on how the recent CMS decision ensures patients have options and why there is still more work to be done to ensure equitable access.
Read MoreWomen undergoing autologous breast reconstruction—in which the breast is reconstructed using the patient’s own tissues—report higher satisfaction with their breasts at follow-up, compared to those undergoing implant-based reconstruction, reports a new study.
Read MoreIn this podcast episode, Dr Constance M. Chen reveals why a thin patient can still be a good candidate for DIEP Flap, or natural tissue breast reconstruction.
Read MoreTF Biologics will be honored with the 2023 Corporate Humanitarian Award at Mission Plasticos’ annual event for their support of reconstructive breast surgery and medical training.
Read MoreRace/ethnicity is not an independent predictor of hospital readmission in patients undergoing breast reconstruction surgery, according to a new study appearing in the August issue of Plastic and Reconstructive Surgery.
Read MoreThe Plastic Surgery Foundation received approval from the U.S. FDA for its Investigational Device Exemption application and will now proceed as sponsor of a prospective, multicenter observational trial studying the impact of acellular dermal matrix and surgical mesh in implant-based breast reconstruction..
Read MoreCollPlant is studying its 3D-bioprinted regenerative breast implant program in large animals—a move that addresses the $2.8 billion global breast implant market, according to company officials.
Read More